• Karlsson, I., Tingstedt, J. L., Şahin, G. Ö., Hansen, M., Szojka, Z., Buggert, M., … Sweden-Guinea-Bissau Cohort Research Group (2019). Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals. The Journal of infectious diseases, 219(11), 1749–1754. doi:10.1093/infdis/jiz001
• Palm, A. A., Lemey, P., Jansson, M., Månsson, F., Kvist, A., Szojka, Z., … Medstrand, P. (2019). Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection. mBio, 10(1), e01245-18. doi:10.1128/mBio.01245-18
• Mahdi, M., Szojka, Z., Mótyán, J. A., & Tőzsér, J. (2018). Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1. Journal of virology, 92(14), e00554-18. doi:10.1128/JVI.00554-18 3.
• Mahdi, M., Szojka, Z., Mótyán, J. A., & Tőzsér, J. (2015). Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System. Viruses, 7(12), 6152–6162. doi:10.3390/v7122931